RRR-ALPHA-TOCOPHERYL SUCCINATE INHIBITS THE PROLIFERATION OF HUMAN PROSTATIC TUMOR-CELLS WITH DEFECTIVE CELL-CYCLE DIFFERENTIATION PATHWAYS

被引:76
作者
ISRAEL, K
SANDERS, BG
KLINE, K
机构
[1] UNIV TEXAS,DIV NUTR SCI A2703,AUSTIN,TX 78712
[2] UNIV TEXAS,INST GENET,AUSTIN,TX 78712
来源
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL | 1995年 / 24卷 / 02期
关键词
D O I
10.1080/01635589509514404
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The RRR-alpha-tocopheryl succinate derivative of vitamin E, referred to as vitamin E succinate (VES), inhibits the proliferation of three metastatic human prostatic cancer cell lines, LNCaP, PC-3, and DU-145. LNCaP is a lymph node-derived androgen-sensitive prostate cell line; these cells are defective for response to transforming growth factor-beta (TGF-beta) but are normal for cell cycle-related tumor suppressor genes: p53 and retinoblastoma (Rb). PC-3 is a bone marrow-derived androgen-insensitive prostate cell line; these cells are defective for both p53 alleles but normal for both Rb alleles. DU-145 is a brain-derived androgen-insensitive prostate cell line; these cells are defective for both p53 and both Rb alleles. VES at 5, 10, and 20 mu g/ml inhibited DNA synthesis in the three cell lines in a dose-dependent manner. Purified TGF-beta(1) at 1 ng/ml inhibited DNA synthesis of PC-3 cells within 24-72 hours and DU-145 cells at 72 hours but did not inhibit DNA synthesis of LNCaP cells. Previous studies in our laboratory showed that VES growth-inhibited tumor cells secrete biologically active antiproliferative factor TGF-beta s, suggesting that VES's mechanism of growth inhibition may involve the TGF-beta system of growth control. The significance of the studies reported here is that VES can inhibit the proliferation of 1) cells that have lost the ability to respond to TGF-beta s (le., LNCaP), 2) cells that are defective for Rb and p53 (i.e., DU-145), and 3) cells that are defective for p53 (i.e., PC-3), critical cell cycle regulatory molecules. Taken together, these studies show that VES most likely inhibits the proliferation of tumor cells via mechanism(s) in addition to and independent of TGF-beta, as well as the functional status of Rb and p53.
引用
收藏
页码:161 / 169
页数:9
相关论文
共 30 条
[1]  
AHUJA SS, 1993, J IMMUNOL, V150, P3109
[2]   ASSOCIATION OF P53 PROTEIN EXPRESSION WITH TUMOR-CELL PROLIFERATION RATE AND CLINICAL OUTCOME IN NODE-NEGATIVE BREAST-CANCER [J].
ALLRED, DC ;
CLARK, GM ;
ELLEDGE, R ;
FUQUA, SAW ;
BROWN, RW ;
CHAMNESS, GC ;
OSBORNE, CK ;
MCGUIRE, WL .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (03) :200-206
[3]   SUPPRESSION OF TUMORIGENICITY OF HUMAN PROSTATE CARCINOMA-CELLS BY REPLACING A MUTATED RB GENE [J].
BOOKSTEIN, R ;
SHEW, JY ;
CHEN, PL ;
SCULLY, P ;
LEE, WH .
SCIENCE, 1990, 247 (4943) :712-715
[4]   RRR-ALPHA-TOCOPHERYL SUCCINATE INHIBITS PROLIFERATION AND ENHANCES SECRETION OF TRANSFORMING GROWTH-FACTOR-BETA (TGF-BETA) BY HUMAN BREAST-CANCER CELLS [J].
CHARPENTIER, A ;
GROVES, S ;
SIMMONSMENCHACA, M ;
TURLEY, J ;
ZHAO, BH ;
SANDERS, BG ;
KLINE, K .
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 1993, 19 (03) :225-239
[5]   RB AND THE CELL-CYCLE - ENTRANCE OR EXIT [J].
COOPER, JA ;
WHYTE, P .
CELL, 1989, 58 (06) :1009-1011
[6]  
CROSS F, 1989, ANNU REV CELL BIOL, V5, P341
[7]   THE PRODUCT OF THE RETINOBLASTOMA SUSCEPTIBILITY GENE HAS PROPERTIES OF A CELL-CYCLE REGULATORY ELEMENT [J].
DECAPRIO, JA ;
LUDLOW, JW ;
LYNCH, D ;
FURUKAWA, Y ;
GRIFFIN, J ;
PIWNICAWORMS, H ;
HUANG, CM ;
LIVINGSTON, DM .
CELL, 1989, 58 (06) :1085-1095
[8]   EXPRESSION AND STATE OF PHOSPHORYLATION OF THE RETINOBLASTOMA SUSCEPTIBILITY GENE-PRODUCT IN CYCLING AND NONCYCLING HUMAN HEMATOPOIETIC-CELLS [J].
FURUKAWA, Y ;
DECAPRIO, JA ;
FREEDMAN, A ;
KANAKURA, Y ;
NAKAMURA, M ;
ERNST, TJ ;
LIVINGSTON, DM ;
GRIFFIN, JD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (07) :2770-2774
[9]  
Horoszewicz JS, 1980, MODELS PROSTATE CANC, P115
[10]  
KLINE K, 1991, VITAMINS AND MINERALS IN THE PREVENTION AND TREATMENT OF CANCER, P189